CEPHIA to present posters at CROI 2014.

From the CEPHIA working group, three posters are to be presented at CROI 2014.

 

Using Antibodies to Detect HIV Persistence in Treatment Intensification and Eradication Studies.

Sheila K. Keating(1,2), Christopher D. Pilcher(2), Gary Murphy(3), Alex Welte(4), Reshma Kassanjee(4), David Matten(4), Mila Lebedeva(1), Steve G. Deeks(5), Michael P. Busch(1,2).

1 BLOOD SYSTEMS RESEARCH INSTITUTE, San Francisco, CA.; 2 UCSF, San Francisco, CA.; 3 PUBLIC HEALTH ENGLAND, London, UNITED KINGDOM.; 4 SACEMA, Stellenbosch, SOUTH AFRICA.; 5 UCSF, Medicine, San Francisco, CA.

 

Application of the GeeniusTM HIV1/2 Supplemental Assay for Detection of Recent HIV Infections.

Sheila M. Keating(1,2), Gary Murphy(3), Alex Welte(4), Reshma Kassanjee(4), David Matten(4), Shelley N. Facente(1), Mila Lebedeva(1), Michael P. Busch(1,2), Christopher D. Pilcher(5), Consortium for Evaluation of Performance of HIV Incidence Assays (CEPHIA).

1 BLOOD SYSTEMS RESEARCH INSTITUTE, San Francisco, CA.; 2 UCSF, San Francisco, CA.; 3 PUBLIC HEALTH ENGLAND, London, UNITED KINGDOM.; 4 SACEMA, Stellenbosch, SOUTH AFRICA.; 5 UCSF, Medicine, San Francisco, CA.; 

 

Independent Evaluation of Predicate Incidence Assays for HIV Surveillance.

Reshma Kassanjee(1), Christopher Pilcher(2), Sheila Keating(3), Shelley Facente(2), Matt Price(4), Jeffrey Martin(2), Susan Little(5), Alex Welte(1), Michael Busch(3), Gary Murphy(6), The Consortium for the Evaluation and Performanceof HIV Incidence Assays (CEPHIA),

1 The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, SOUTH AFRICA.; 2 University of California, San Francisco, San Francisco, CA.; 3 Blood Systems Research Institute, San Francisco, CA.; 4 International AIDS Vaccine Initiative (IAVI), Department of Medical Affairs, New York City, NY.; 5 University of California San Diego, Department of Medicine, San Diego, CA.; 6 Health Public England, London, UNITED KINGDOM.